NeuroSense Therapeutics Ltd. Other Gains Losses
NeuroSense Therapeutics Ltd. (NRSN) reported Other Gains Losses of $5.71 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Income Statement › Other Income
ifrs-full:OtherGainsLosses · last filed 2024-04-04
| Period end | Other Gains Losses 6 month | Other Gains Losses 12 month |
|---|---|---|
| 2023-12-31 | $5.71M 20-F · filed 2024-04-04 | |
| 2023-06-30 | $3.11M 6-K · filed 2023-08-16 | |
| 2022-12-31 | $7.14M 6-K · filed 2023-08-16 | $7.14M 20-F · filed 2024-04-04 |
| 2022-06-30 | $3.69M 6-K · filed 2023-08-16 | |
| 2021-12-31 | $2.50M 20-F · filed 2024-04-04 | |
| 2020-12-31 | $393.00K 20-F · filed 2023-03-22 |